Souza P.P., Völkel P., Trinel D., Vandamme J., Rosnoblet C., Héliot L. & Angrand P.-O. (2009)
The histone methyltransferase SUV420H2 and Heterochromatin Proteins HP1 interact but show different dynamic behaviours.
BMC Cell Biology, 1;10: 41
The control of histone lysine methylation in epigenetic regulation.
Biochimie, 89: 1-20
Angrand P.-O., Segura I., Völkel P., Ghidelli S., Terry R., Brajenovic M., Vintersten K., Klein R., Superti-Furga G., Drewes G., Kuster B., Bouwmeester T. & Acker-Palmer A. (2006)
Transgenic mouse proteomics identifies new 14-3-3 associated proteins involved in cytoskeletal rearrangements and cell signaling.
Molecular and Cellular Proteomics, 5: 2211-2227.
Vandamme J. & Angrand P.-O. (2006)
La méthylation des histones n'est plus ce qu'elle était.
médecine/sciences, 22: 361-363.
Bouwmeester T., Bauch A., Ruffner H., Angrand P.-O., Bergamini G., Croughton K., Eberhart D., Gagneur J., Ghidelli S., Hopf C., Huhse B., Mangano R., Michon A.-M., Schirle M., Schlegl J., Schwab M., Stein M., Bauer A., Casari G., Drewes G., Gavin A.-C., Jackson D.B., Joberty G., Neubauer G., Rick J.M., Kuster B. & Superti-Furga G. (2004)
A physical and functional map of the human TNFa / NF-kB signal transduction pathway.
Nature Cell Biology, 6: 97-105.
Hopf C., Angrand P.-O., Gagneur J., Hefferman B., Mangano R., Pichard
L., Ruffner H., O'Sullivan E., Stein M., Thomas S., Völkel P., Kuster
B., Choudary J., Rowley A. & Drewes G. (2004)
Proteomic analysis of amyloid precursor protein processing complexes in human neuroblastoma cells by tandem affinity purification.
Neurology of Aging, 25: S37.
Rayasam G.V., Wendling O., Angrand P.-O., Mark M., Niederreither K., Song L., Lerouge T., Chambon P. & Losson R. (2003)
NSD1 is essential for early post-implantation development and has a catalytically active SET domain.
EMBO Journal, 22: 3153-3163.
Ren S.-Y., Angrand P.-O. & Rijli F.M. (2002)
A targeted insertion results in a rhombomere 2-specific Hoxa2 knockdown and ectopic activation of Hoxa1 expression
Developmental Dynamics, 225: 305-315.
Angrand P.-O., Apiou F., Stewart A.F., Dutrillaux B., Losson R. & Chambon P. (2001)
NSD3, a new SET domain-containing gene, maps to 8p12 and is amplified in human breast cancer cell lines.
Genomics, 74: 79-88.
Ringrose L., Chabanis S., Angrand P.-O., Woodroofe C. & Stewart A.F. (1999)
Quantitative comparison of DNA looping in vitro and in vivo: Chromatin increases effective DNA flexibility at short distances.
EMBO Journal, 18: 6630-6641.
Angrand P.-O., Daigle N., van der Hoeven F., Schöler H.R. & Stewart A.F. (1999)
Simplified generation of targeting constructs using of ET recombination.
Nucleic Acids Research, 27: e16.
Buchholz F., Angrand P.-O. & Stewart A.F. (1998)
Improved properties of FLP recombinase evolved by cycling mutagenesis.
Nature Biotechnology, 16: 657-662.
Angrand P.-O., Woodroofe C.P., Buchholz F. & Stewart A.F. (1998)
Inducible gene expression system based on a regulated FLP recombinase integrated into mammalian cells in a single step.
Nucleic Acids Research, 26: 3263-3269.
Schwenk F., Kühn R., Angrand P.-O., Rajewsky K. & Stewart A.F. (1998)
Temporally and spacially regulated somatic mutagenesis in mice.
Nucleic Acids Research, 26: 1427-1432.
Ringrose L., Angrand P.-O. & Stewart A.F. (1997)
The Kw recombinase, an integrase from the Kluyveromyces waltii.
European Journal of Biochemistry, 248: 903-912.
Angrand P.-O, Woodroofe C.P. & Stewart A.F. (1997)
Application of ligand-dependent site-specific recombination in ES cells.
In "Microinjection and Transgenesis of Cultured Cells and Embryos - Strategies and protocols". Springer Lab Manual. Cid-Arregui A. & Garcia-Carranca A. Eds. Springer-Verlag, Heidelberg, New-York, Tokyo. pp 255-274.
Buchholz F., Ringrose L., Angrand P.-O., Rossi F. & Stewart A.F. (1996)
Different thermostabilities of FLP and Cre recombinases: implications for applied site-specific recombination.
Nucleic Acids Research, 24: 4256-4262.
Buchholz F., Angrand P.-O. & Stewart A.F. (1996)
A simple assay to determine the functionality of Cre or FLP recombination targets in genomic manipulation constructs.
Nucleic Acids Research, 24: 3118-3119.
Kellendonk C., Tronche F., Monaghan A.-P., Angrand P.-O., Stewart A.F. & Schütz G. (1996)
Regulation of Cre recombinase activity by the synthetic steroid RU 486.
Nucleic Acids Research, 24: 1404-1411.
Angrand P.-O., Coffinier C. & Weiss M.C. (1994)
Response of the phosphoenolpyruvate carboxykinase gene promoter to glucocorticoids depends on the activation of the cAMP pathway.
Cell Growth and Differentiation, 5: 957-966.
Angrand P.-O. (1993)
Les domaines de liaison à l’ADN des facteurs de transcription eucaryotes.
médecine/sciences, 9: 725-736.
Griffo G., Hamon-Benais C., Angrand P.-O., Fox M., West L., Lecoq O., Povey S., Cassio D. & Weiss M.C. (1993)
HNF4 and HNF1 as well as a panel of hepatic functions are extinguished and reexpressed in parallel in chromosomally reduced rat hepatoma-human fibroblast hybrids.
Journal of Cell Biology, 121: 887-898.
Angrand P.-O., Rousset J.-P. & Weiss M.C. (1992)
Cell phenotype, binding affinity, and promoter structure modulate transactivation by HNF1 and LAP.
Journal of Cell Science, 103: 1083-1092.
Cassan M., Bertaux V., Angrand P.-O. & Rousset J.-P. (1990)
Expression vectors for quantitating in vivo translational ambiguity : their potential use to analyse frameshifting at the HIV gag-pol junction.
Research in Virology, 141: 597-610.
Angrand P.-O., Kallenbach S., Weiss M.C. & Rousset J.-P. (1990)
An exogenous albumin promoter can become silent in dedifferentiated variants as well as intertypic hybrids.
Cell Growth and Differentiation, 1: 519-526.
